Back
Astellas Pharma Vs. Takeda Pharmaceutical Industry Stock Comparison
Sell
33
ALPMY
Astellas Pharma
Last Price:
11.15
Seasonality Move:
1.26%
Sell
35
TAK
Takeda Pharmaceutical
Last Price:
13.75
Seasonality Move:
4.98%
Sell
33
Astellas Pharma (ALPMY)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMY] share price is $11.40. The Score for ALPMY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ALPMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy, Sell or Hold?
- The current Takeda Pharmaceutical [TAK] share price is $14.22. The Score for TAK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- TAK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALPMY Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $11.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing selling pressure, which indicates risk of future bearish movement.
TAK Stock Price Chart
What is Takeda Pharmaceutical's stock price today?
-
The Takeda Pharmaceutical share price today is $14.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TAK is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALPMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 44.53 | Sell |
| Chaikin Money Flow: | -54450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.42 - 11.82) | Sell |
| Bollinger Bands (100): | (10.39 - 12.21) | Buy |
TAK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 53.47 | Buy |
| Chaikin Money Flow: | 724645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.86 - 14.34) | Buy |
| Bollinger Bands (100): | (13.34 - 14.7) | Buy |
ALPMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.63 | Sell |
| 20-day SMA: | 11.63 | Sell |
| 50-day SMA: | 11.92 | Sell |
| 200-day SMA: | 10.87 | Buy |
| 8-day EMA: | 11.62 | Sell |
| 20-day EMA: | 11.66 | Sell |
| 50-day EMA: | 11.66 | Sell |
| 200-day EMA: | 11.47 | Sell |
TAK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.89 | Buy |
| 20-day SMA: | 14.05 | Buy |
| 50-day SMA: | 14.46 | Sell |
| 200-day SMA: | 13.95 | Buy |
| 8-day EMA: | 14 | Buy |
| 20-day EMA: | 14.07 | Buy |
| 50-day EMA: | 14.2 | Buy |
| 200-day EMA: | 14.14 | Buy |
Astellas Pharma Earnings Growth & ALPMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Takeda Pharmaceutical Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||